Dr. Nirni Sharanabasappa Somanath Medical Oncologist in Hyderabad

Dr. Nirni Sharanabasappa Somanath

Medical Oncologist, Hyderabad

MBBS, MD (Internal Medicine), DM (Haemato-Oncology)

  • 1 Hospital

About

  • Worked as consultant Medical Oncologist and Hematologist at Apollo Cancer Hospital, Hyderabad(350 bedded super specialty Hospital for 2 years)
  • Worked as Observer in Bone Marrow Transplant unit at St. Vincent Hospital (New York Medical School) New York
  • Worked as clinical observer in Bone Marrow Transplant unit at Queen’s Elizabeth Hospital, Birmingham – U.K 
  • Presently working as Senior Medical Oncologist & Hematologist at Indo American Cancer Institute & Research Centre, Hyderabad (350 bedded Cancer Hospital)
  • Worked as Senior Registrar in Medical oncology Department ICU in Jaslok Hospital and Research Center Mumbai for 6 months.
  • Worked as Senior Registrar in Medical ICU in Leelavati Hospital and Research Center Mumbai for 6 months
  • Worked as Registrar in Department of Medical oncology in Kidwai Memorial Institute of Oncology Bangalore for 3 months.
  • Worked as Medical assistant in Kasturba Infectious Disease Hospital Mumbai for 1 year
  • Languages : English, Hindi, Telugu, Kannada, Marathi, Gujarati

Specialities

  • Medical Oncology

  • Hemato Oncology

Expertise

Education

  • MBBS  From M.R. Medical College, Gulbarga University. Gulbarga Karnataka, India
  • MD (Internal Medicine) from M.R. Medical College, Gulbarga University. Gulbarga Karnataka, India
  • DM (Haemato – Oncology) from Gujarat Cancer and Research Institute, Gujarat University. Ahmedabad, Gujarat, India

Practice Information

Omega Hospitals, Banjara Hills

Omega Hospitals, Banjara Hills

MLA Colony Main Raod, Road No - 12, Banjara Hills, Hyderabad, Telangana - 500034

Achievements & Contributions

  • INTERNATIONAL DRUG TRAIL:GEMCITE + PACLITAXOL Vs PACLITAXOL in metastatic breast cancer
  • Study of two different dosing regimens of Capecitabine in Combination with intravenous Docetaxel in metastatic Breast Cancer
  • Ovarian Cancer Phase II US FDA Study , Co-Investigator 3
  • NSCLC Phase III US FDA Study , Co-Investigator 
  • Chemotherapy Induced Nausea & Vomiting , Phase III , US FDA Study – Principal Investigator 
  • Chemotherapy Induced Neutropenia, Phase III Study, Principal Investigator
  • “Use of Intravasular devices and its complication” at ASCO PAN ASIA Conference in February 2002 in New Delhi
  • “Study of Concurrent CT/RT with RT in locally advanced Nasopharyngeal cancer” at National conference of cancer & Research held at Trivendrum in January 2003
  • “Study of Rhabdomyosarcoma a GCRI experience” at National Conference of Pediatric Oncology in Ahmedabad in August 2002
  • “Study of Osteosarcoma a GCRI experience” at National Conference of Pediatric Oncology in Ahmedabad in August 2002
  • “Clinical Study and Recent advances in CML” at Annual conference of Gujarat Physician Association, in Ahmedabad August 2001
  • Indian Society of Medical and Pediatric Oncology
  • Association of Physician of India
-->